tiprankstipranks
Trending News
More News >
Saniona AB (SE:SANION)
:SANION

Saniona AB (SANION) Price & Analysis

Compare
0 Followers

SANION Stock Chart & Stats


---

Financials

Quarterly

SANION FAQ

What was Saniona AB’s price range in the past 12 months?
Saniona AB lowest stock price was kr1.74 and its highest was kr9.91 in the past 12 months.
    What is Saniona AB’s market cap?
    Saniona AB’s market cap is kr992.02M.
      When is Saniona AB’s upcoming earnings report date?
      Saniona AB’s upcoming earnings report date is May 21, 2025 which is in 26 days.
        How were Saniona AB’s earnings last quarter?
        Saniona AB released its earnings results on Feb 27, 2025. The company reported kr2.209 earnings per share for the quarter, beating the consensus estimate of N/A by kr2.209.
          Is Saniona AB overvalued?
          According to Wall Street analysts Saniona AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Saniona AB pay dividends?
            Saniona AB pays a Notavailable dividend of kr0.1 which represents an annual dividend yield of N/A. See more information on Saniona AB dividends here
              What is Saniona AB’s EPS estimate?
              Saniona AB’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Saniona AB have?
              Saniona AB has 135,521,840 shares outstanding.
                What happened to Saniona AB’s price movement after its last earnings report?
                Saniona AB reported an EPS of kr2.209 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -11.056%.
                  Which hedge fund is a major shareholder of Saniona AB?
                  Currently, no hedge funds are holding shares in SE:SANION
                  ---

                  Company Description

                  Saniona AB

                  Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, NS2359, and CAD-1883.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Guard Therapeutics International AB
                  IRLAB Therapeutics AB Class A
                  Xbrane Biopharma AB
                  Xspray Pharma AB
                  SynAct Pharma AB
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis